Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep;92(2):320-5.
doi: 10.1007/s12185-010-0653-2. Epub 2010 Aug 10.

Absence of gain-of-function JAK1 and JAK3 mutations in adult T cell leukemia/lymphoma

T Kameda  1 , K Shide, H K Shimoda, T Hidaka, Y Kubuki, K Katayose, Y Taniguchi, M Sekine, A Kamiunntenn, K Maeda, K Nagata, T Matsunaga, K Shimoda
Affiliations

Absence of gain-of-function JAK1 and JAK3 mutations in adult T cell leukemia/lymphoma

T Kameda et al. Int J Hematol. 2010 Sep.

Abstract

Janus kinase 1 (JAK1) and JAK3 plays a critical role in lymphocyte proliferation and differentiation. Somatic JAK1 mutations are found in 18% of adult precursor T acute lymphoblastic leukemias and somatic JAK3 mutations are found in 3.3% of cutaneous T cell lymphomas. Some of the mutations are confirmed as a gain-of-function mutation and are assumed to be involved in leukemogenesis. Adult T cell leukemia/lymphoma (ATLL) is a type of T cell neoplasm, and activation of JAK/STAT pathways is sometimes observed in them. We investigated JAK1 and JAK3 mutations in 20 ATLL patients. No JAK1 mutations were found, and five types of single nucleotide polymorphisms were observed in 12 cases, whose frequencies almost match those in Asian populations. As for JAK3, a synonymous mutation was found in one case. JAK1 and JAK3 mutations are unlikely involved in the leukemogenesis of ATLL.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Immunol Rev. 2009 Mar;228(1):273-87 - PubMed
    1. Clin Cancer Res. 2008 Jun 15;14(12):3716-21 - PubMed
    1. Int Rev Immunol. 2007 Sep-Dec;26(5-6):269-81 - PubMed
    1. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5389-93 - PubMed
    1. Leuk Res. 2004 Jan;28(1):71-82 - PubMed

LinkOut - more resources